Innovator of The Year Nominee for the Orange County Business Journal With over 30 years of brand and product development experience in the nutraceutical, pharmaceutical, and medical device sectors, Edalat founded Vivera to create a pharmaceutical company whose core mission would be to put patients first. His forward-thinking management approach as CEO has seen Vivera Pharmaceuticals grow from a single division at its founding to over six divisions and counting today. Leading Vivera’s business development domestically and internationally, Edalat works closely with Vivera’s sales and marketing teams to anticipate and meet market demands. With trusted global relationships built over the decades, Edalat has worked to leverage his connections and expand Vivera’s reach. In addition, he has led the company through innovative research and development at home.

CEO Visionary – LA Times B2B Publishing C-Suite Magazine As a founding partner, CEO, and chairman of Vivera Pharmaceuticals, Paul Edalat is a visionary industry disruptor driven by his desire to transform the pharmaceutical industry to serve patients and consumers better. Edalat’s mission is to upend an outdated industry to improve the lives and well-being of all Americans regardless of race, socioeconomics, or any other social determinant of health. He is a true believer in the power of future-focused medicine to ensure equitable health opportunities for all. Edalat is dedicated to making a positive difference for vulnerable communities worldwide. When the global pandemic hit in 2020, he knew his team had to step up to help the community. Vivera already had an entire pharmaceutical team that was the perfect fit to help distribute COVID-19 testing. The team wanted to help ease Americans’ anxiety, which started with providing no-cost testing to numerous organizations across the United States.

Excellence in Entreprenuership Nominee for the Orange County Business Journal As a founding partner, CEO, and chairman of Vivera Pharmaceuticals, Paul Edalat is a visionary industry disruptor driven by his desire to transform the pharmaceuticals industry to better serve patients and consumers. Edalat’s mission is to upend an outdated industry to improve the lives and wellbeing of all Americans: regardless of race, socioeconomics, or any other social determinant of health. He is a true believer in the power of future-focused medicine to ensure equitable health opportunities for all. Working with Vivera’s team of scientists, doctors, and advisors, the company is leading the way with innovative new technologies such as its patented ZICOH, a drug delivery device, and the patented TABMELT, sublingual drug delivery system. Together with the team, Edalat leads a whole-patient approach to treatment, focusing on the synergistic roles mental and physical health have together. With the company’s expansion into medical technologies and neurosciences, Edalat wants to bring a fresh new perspective to just how patient care can be achieved.

CEO Views: Vivera Pharmaceuticals: Making a Difference in Patient Lives During an interview with CEO Views, Paul Edalat, Chairman and CEO of Vivera, shared his insights on the topic and how Vivera plans to use innovative technology to address the opioid crisis.